XIAP and colorectal cancer: As shown in the left panel of Fig. 1f, less survivin was co-immunoprecipitated with XIAP in colorectal cancer cells treated by Sur-X for 1 h; similarly, the right panel indicated a significant reduction of XIAP in survivin-immunocomplexes in Sur-X-treated cells.